ArticleScientific reports2025
Determination of disintegration time using formulation data for solid dosage oral formulations via advanced machine learning integrated optimizer models.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Application of AI in Tablet Development: An Integrated Machine Learning Framework for Pre-Formulation Property Prediction.Pharmaceutics · 2026Article
- Computational machine learning analysis and validation for estimation of viscosity of ionic liquids versus temperature and composition.Frontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We evaluated the properties of tablets by artificial intelligence and machine learning computational approach with integration of optimizer. A large dataset on formulations properties and corresponding tablet disintegration time was collected and the models were used to fit the dataset. Utilizing a dataset of approximately 2,000 entries encompassing molecular properties, physical properties, excipient composition, and formulation characteristics, three ML models were evaluated: TabNet, Radial Basis Function Support Vector Regression (RBF-SVR), and Neural Oblivious Decision Ensembles (NODE). Data preprocessing involved Min-Max normalization, outlier detection via Elliptic Envelope, and feature selection using Conditional Mutual Information, with hyperparameters optimized through the Water Cycle Algorithm. Performance was assessed using R², RMSE, and MAE across train, validation, and test sets, with 95% confidence intervals confirming robust predictions. NODE demonstrated great accuracy for fitting the data, with the highest calculated test R² (0.9805) and the lowest RMSE (7.078) and MAE (5.913), outperforming TabNet (R²: 0.9657, RMSE: 9.382, MAE: 7.299) and RBF-SVR (R²: 0.9652, RMSE: 9.452, MAE: 7.127). These findings highlight NODE's efficacy in modeling complex data relationships, offering significant potential for optimizing tablet formulations in pharmaceutical research to design proper fast-disintegrating tablets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.